熱門資訊> 正文
MannKind首席财务官Steven Binder退休
2024-03-27 04:13
- MannKind (NASDAQ:MNKD) announced that Steven Binder will retire from his position as Chief Financial Officer, effective April 22, 2024.
- Christopher Prentiss has been appointed as CFO, effective April 22, 2024.
- Binder plans to remain at MannKind through the end of the year as Executive Vice President, Special Projects.
- Since September 2022, Prentiss has served as CFO of ADARx Pharmaceuticals, a privately held clinical-stage biotechnology company. He also held a series of finance positions at the commercial-stage biotech company Adamas Pharmaceuticals.
More on MannKind
- MannKind's Tyvaso DPI Royalty Deal Signals Undervaluation
- MannKind Q4 2023 Earnings Preview
- MannKind, Sagard Healthcare enter $200M royalty purchase deal
- Seeking Alpha’s Quant Rating on MannKind
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
